FORT LAUDERDALE, Fla.,
April 24, 2012 /PRNewswire/
-- Nouveau Life Pharmaceuticals, soon to be changed from
Hybrid Fuels, Inc., (Pink Sheets: HRID) announced today that it has
contracted with an FDA-approved manufacturer to begin production of
the first supplement in its New Life Naturals™ product
line.
The new supplement – New Life Naturals: For Her
Senses™ – is an all-natural product intended to help
the nearly 48% of American women suffering with female sexual
dysfunction (FSD). Nouveau Life Pharmaceuticals began work on the
supplement's formulation in February of this year and finalized the
formula ahead of schedule.
In order to minimize time-to-market and begin production
immediately, Nouveau Life opted to partner with an FDA-approved
manufacturing facility based in the U.S. The facility is a cGMP
(current good manufacturing practice) compliant facility and meets
all FDA requirements to manufacture food supplements and over the
counter pharmaceuticals.
Nouveau Life expects production of the For Her
Senses™ supplement to begin in the coming days and
anticipates the nutraceutical will be available for sale to the
public within two weeks.
About Hybrid Fuels, Inc.
The company was incorporated in the state of Nevada in 1998 as Polo Equities. It has
primarily been a development stage company with management focused
on developing innovative business opportunities and further
advancing technologies.
Forward-Looking Statements - This press release contains
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Such statements are subject to risks and uncertainties that could
cause future results to differ materially from the forward-looking
statements. You should consider these factors in evaluating the
statements herein, and not rely on such statements. The
forward-looking statements in this release are made as of the date
hereof and Hybrid Fuels, Inc. undertakes no obligation to update
such statements.
CONTACT:
Nouveau Life Pharmaceuticals, Inc. - 954-903-2993
SOURCE Nouveau Life Pharmaceuticals, Inc.